搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
2 小时
Regenerative Neuropathy offers life-changing neuropathy treatment; get a special offer today!
SPONSORED – Neuropathy is becoming a bigger problem for more people than ever before. If you`re suffering from stabbing pain, ...
The Bluffton Icon
3 天
Weekend Doctor: Peripheral neuropathy
Diabetic peripheral neuropathy, which affects about 30% of diabetics, can cause numbness, tingling, or burning in the feet.
casereports.bmj
4 天
Peripheral neuropathy following monkeypox infection: an unexpected diagnosis of Parsonage ...
Parsonage-Turner syndrome following monkeypox infection is a rare form of peripheral neuropathy seen in orthopaedic practice ...
lebtown
1 天
Dr. Michael Fishman champions spinal cord stimulation for diabetic neuropathy treatment
At his practice on-site at Lebanon Internal Medicine Associates, Dr. Fishman utilizes advanced technology now offering ...
money.rediff
12 天
Alkem Licenses Drug for Diabetic Neuropathy in India
Alkem Laboratories partners with Sonnet BioTherapeutics to develop and commercialize SON-080, a potential treatment for ...
Times Argus
10 天
Sancic: Understanding peripheral neuropathy
Peripheral neuropathy is a complex and often debilitating condition that affects millions of people worldwide. Research estimates around 10% of the general population experiences some form of ...
Daily
10 天
Alkem Labs inks pact with Sonnet BioTherapeutics to develop, commercialise drug candidate ...
Mumbai: Alkem Laboratories Ltd. has entered into a licensing agreement with US-based Sonnet BioTherapeutics Holdings, Inc to ...
13 天
Sonnet Partners Alkem To Develop And Market SON-080 For Diabetic Peripheral Neuropathy In India
Sonnet BioTherapeutics Holdings, Inc. (SONN) announced Wednesday that it has entered into a licensing agreement with Alkem ...
Business Wire
4 天
Vertex to Present Phase 3 Data Highlighting Suzetrigine’s Potential as a First-in-Class ...
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the company will present its pivotal Phase 3 data on ...
12 天
Sonnet BioTherapeutics’ Strategic Deal to Develop DPN Treatment
Sonnet BioTherapeutics Holdings ( (SONN) ) has issued an update. Sonnet BioTherapeutics Holdings, Inc. has partnered with ...
cnbctv18
12 天
Alkem Labs signs licensing agreement with Sonnet BioTherapeutics to develop diabetic ...
Under the licensing agreement, Alkem will carry out the clinical development of 'SON-080' in India with support from Sonnet ...
当前正在显示可能无法访问的结果。
隐藏无法访问的结果
反馈